Cargando…
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
Antisense oligonucleotides (ASOs) are single-stranded nucleic acid strings that can be used to selectively modify protein synthesis by binding complementary (pre-)mRNA sequences. By specific arrangements of DNA and RNA into a chain of nucleic acids and additional modifications of the backbone, sugar...
Autores principales: | Helm, Jacob, Schöls, Ludger, Hauser, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416334/ https://www.ncbi.nlm.nih.gov/pubmed/36015334 http://dx.doi.org/10.3390/pharmaceutics14081708 |
Ejemplares similares
-
Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021) -
Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases
por: Lin, Mengsi, et al.
Publicado: (2021) -
Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
por: Anderson, Brian R., et al.
Publicado: (2020) -
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
por: Bonifert, Tobias, et al.
Publicado: (2016) -
Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)